AHE
ADHERIS FPO [AHE]
Healthcare · ASX Small Cap
$0.0200 +0.0%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical59
Catalyst50
Sentiment50
Fundamental52
Momentum53
Risk Gate45
Get alerts when AHE's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD momentum is losing steam
- Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
- Drifting lower — down 4.8% over the last 5 days
- Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Low cash runway (2 quarters) - dilution risk
- Low P/S ratio (0.3x)
- Revenue in sharp decline (-49%)
- Post-earnings drift: positive surprise (SUE +10)
- Micro-cap ($5-20M) - high risk
- CANSLIM C: Strong EPS growth (424% QoQ)
- CANSLIM A: Turned profitable
- CANSLIM I: Institutional ownership (32%)
- Sentiment is mixed — no strong consensus either way
- Earnings are trending the right way — 2 consecutive improvements
- The bigger volume days are the up days — volume-weighted momentum is positive (1.21%/day)
- Low-priced stock risk ($0.020)
- RBA hiking (-3pts)
Risk Signals
- Deeply negative margins (-134%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -49% — the top line is shrinking
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about AHE
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE EGM - Results of Meeting
NONE Appendix 3Y - Lucas Merrow
NONE Appendix 3Y - Lucas Merrow
Recent ASX Announcements
| 2026-03-12 | EGM - Results of Meeting |
| 2026-03-11 | Appendix 3Y - Lucas Merrow |
| 2026-03-09 | Appendix 3Y - Lucas Merrow |
| 2026-03-08 | Appendix 3Y - Kate Hill |
| 2026-03-02 | Adheris Health EGM - new virtual meeting link |
Key Metrics
$12.7M
Market Cap
469K
Avg Volume
0.7x
Vol Ratio
$0.02 — $0.03
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-177.9%
ROE
-133.6%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | pass | EPS Growth: 424% |
| A | Annual Earnings | improving | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 62% |
| L | Leader vs Laggard | laggard | RS: -2 |
| I | Institutional Sponsorship | pass | Inst: 32% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #37 of 117 · Sector avg: 46
View all Healthcare signals →Track AHE and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required